逸仙资本指导保康士集团的战略股权转让

逸仙资本担任独家卖房财务顾问,指导澳大利亚保康士集团的战略股权转让至中国最大的食品饮品公司和中国传统中药公司之一 – 天津狗不理集团。总交易额约为6千万澳币,于2017年7月最终完成。

YSA advises Blooms Health Products Sale

YSA acted as exclusive financial advisor to Blooms Health Products on its strategic share sale to Goubuli Group, one of China’s leading F&B and Traditional Chinese Medicine groups, for AUD $60 million.  This transaction closed in July 2017.